KORU Medical Systems Debt to Equity Ratio 2010-2025 | KRMD

Current and historical debt to equity ratio values for KORU Medical Systems (KRMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. KORU Medical Systems debt/equity for the three months ending March 31, 2025 was 0.01.
KORU Medical Systems Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.01B $0.02B 0.67
2024-12-31 $0.01B $0.02B 0.62
2024-09-30 $0.01B $0.02B 0.55
2024-06-30 $0.01B $0.02B 0.46
2024-03-31 $0.01B $0.02B 0.44
2023-12-31 $0.01B $0.02B 0.40
2023-09-30 $0.01B $0.03B 0.29
2023-06-30 $0.01B $0.03B 0.28
2023-03-31 $0.01B $0.03B 0.28
2022-12-31 $0.01B $0.03B 0.35
2022-09-30 $0.01B $0.03B 0.31
2022-06-30 $0.01B $0.03B 0.30
2022-03-31 $0.01B $0.04B 0.25
2021-12-31 $0.01B $0.04B 0.13
2021-09-30 $0.01B $0.04B 0.12
2021-06-30 $0.00B $0.04B 0.09
2021-03-31 $0.01B $0.04B 0.12
2020-12-31 $0.00B $0.04B 0.10
2020-09-30 $0.01B $0.04B 0.14
2020-06-30 $0.01B $0.04B 0.22
2020-03-31 $0.00B $0.01B 0.37
2019-12-31 $0.00B $0.01B 0.24
2019-09-30 $0.00B $0.01B 0.25
2019-06-30 $0.00B $0.01B 0.24
2019-03-31 $0.00B $0.01B 0.26
2018-12-31 $0.00B $0.01B 0.18
2018-09-30 $0.00B $0.01B 0.16
2018-06-30 $0.00B $0.01B 0.18
2018-03-31 $0.00B $0.01B 0.15
2017-12-31 $0.00B $0.01B 0.21
2017-09-30 $0.00B $0.01B 0.17
2017-06-30 $0.00B $0.01B 0.14
2017-03-31 $0.00B 0.00
2017-02-28 $0.00B $0.01B 0.22
2016-11-30 $0.00B $0.01B 0.26
2016-09-30 $0.00B 0.00
2016-08-31 $0.00B $0.01B 0.23
2016-06-30 $0.00B 0.00
2016-05-31 $0.00B $0.01B 0.20
2016-02-29 $0.00B $0.01B 0.18
2015-11-30 $0.00B $0.01B 0.21
2015-08-31 $0.00B $0.01B 0.18
2015-05-31 $0.00B $0.01B 0.20
2015-02-28 $0.00B $0.01B 0.16
2014-11-30 $0.00B $0.01B 0.23
2014-08-31 $0.00B $0.01B 0.20
2014-05-31 $0.00B $0.01B 0.24
2014-02-28 $0.00B $0.01B 0.20
2013-11-30 $0.00B $0.01B 0.17
2013-08-31 $0.00B $0.01B 0.18
2013-05-31 $0.00B $0.00B 0.17
2013-02-28 $0.00B $0.00B 0.28
2012-11-30 $0.00B $0.00B 0.32
2012-08-31 $0.00B $0.00B 0.31
2012-05-31 $0.00B $0.00B 0.32
2012-03-31 $0.00B 0.00
2012-02-29 $0.00B $0.00B 0.35
2011-12-31 $0.00B $0.00B 0.35
2011-11-30 $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.33
2011-08-31 $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.39
2011-05-31 $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.38
2011-02-28 $0.00B 0.00
2010-12-31 $0.00B $0.00B 0.45
2010-09-30 $0.00B $0.00B 0.49
2010-06-30 $0.00B $0.00B 0.70
2010-03-31 $0.00B $0.00B 0.77
2009-12-31 $0.00B $0.00B 1.31
2009-09-30 $0.00B $0.00B 1.37
2009-06-30 $0.00B $0.00B 1.92
2009-03-31 $0.00B $0.00B 2.29
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.149B $0.034B
KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Hims & Hers Health (HIMS) United States $11.646B 121.00
Doximity (DOCS) United States $11.561B 53.52
Tempus AI (TEM) United States $10.010B 0.00
IRhythm Technologies (IRTC) United States $4.435B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.739B 0.00
Privia Health (PRVA) United States $2.547B 174.08
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.642B 0.00
Schrodinger (SDGR) United States $1.551B 0.00
10x Genomics (TXG) United States $1.535B 0.00
Clover Health Investments (CLOV) United States $1.527B 0.00
Azenta (AZTA) United States $1.475B 68.57
Evolent Health (EVH) United States $1.334B 113.60
Omnicell (OMCL) United States $1.291B 22.78
Claritev (CTEV) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.582B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.450B 0.00
Talkspace (TALK) United States $0.430B 128.50
Outset Medical (OM) United States $0.333B 0.00
TruBridge (TBRG) United States $0.329B 731.00
Health Catalyst (HCAT) United States $0.269B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.203B 0.00
Zepp Health (ZEPP) Netherlands $0.139B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.091B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00